Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$219K Buy
2,128
+53
+3% +$5.71K 0.19% 156
2023
Q2
$239K Sell
2,075
-147
-7% -$16.7K 0.19% 143
2023
Q1
$236K Sell
2,222
-3
-0.1% -$324 0.18% 177
2022
Q4
$247K Sell
2,225
-718
-24% -$73.4K 0.21% 131
2022
Q3
$253K Buy
2,943
+180
+7% +$16.1K 0.22% 102
2022
Q2
$252K Sell
2,763
-172
-6% -$15.2K 0.21% 117
2022
Q1
$241K Sell
2,935
-644
-18% -$50.8K 0.2% 156
2021
Q4
$274K Buy
+3,579
New +$285K 0.2% 145

Other funds holding MRK

Syntax Advisors's MRK Position: Q3 2023 in Review

Syntax Advisors increased its Merck (MRK) stake by 2.6% in Q3 2023, buying an estimated $5.71K and bringing the position to 2,128 shares worth $219K. The position accounts for 0.19% of the portfolio, ranked #156.

Syntax Advisors first reported a position in MRK in Q4 2021 and has held it in 8 quarters since. The position peaked at $274K in Q4 2021. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Syntax Advisors held 2,128 shares of Merck worth $219K as of Q3 2023.
  • Syntax Advisors bought 53 Merck shares in Q3 2023, an estimated $5.71K.
  • Merck made up 0.19% of Syntax Advisors's portfolio in Q3 2023, its #156 holding.
  • Syntax Advisors first reported a position in Merck in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Merck position peaked at $274K in Q4 2021.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.